ATE376674T1 - Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system - Google Patents
Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-systemInfo
- Publication number
- ATE376674T1 ATE376674T1 AT04764118T AT04764118T ATE376674T1 AT E376674 T1 ATE376674 T1 AT E376674T1 AT 04764118 T AT04764118 T AT 04764118T AT 04764118 T AT04764118 T AT 04764118T AT E376674 T1 ATE376674 T1 AT E376674T1
- Authority
- AT
- Austria
- Prior art keywords
- transthyretin
- colorectal
- biomarker
- directed
- adenoma
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Steroid Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2004/009124 WO2006015616A1 (en) | 2004-08-13 | 2004-08-13 | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE376674T1 true ATE376674T1 (de) | 2007-11-15 |
Family
ID=34958684
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04764118T ATE376674T1 (de) | 2004-08-13 | 2004-08-13 | Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system |
| AT05772471T ATE419534T1 (de) | 2004-08-13 | 2005-08-11 | Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05772471T ATE419534T1 (de) | 2004-08-13 | 2005-08-11 | Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7951528B2 (de) |
| EP (3) | EP1843159A1 (de) |
| JP (2) | JP4916441B2 (de) |
| KR (1) | KR20070051328A (de) |
| CN (2) | CN101014859A (de) |
| AT (2) | ATE376674T1 (de) |
| AU (2) | AU2004322162B2 (de) |
| BR (1) | BRPI0419002A (de) |
| CA (2) | CA2577601A1 (de) |
| DE (2) | DE602004009716T2 (de) |
| DK (2) | DK1761779T3 (de) |
| ES (2) | ES2295907T3 (de) |
| IL (2) | IL181132A (de) |
| MX (2) | MX2007001479A (de) |
| NO (2) | NO20070598L (de) |
| PL (2) | PL1761779T3 (de) |
| PT (2) | PT1761779E (de) |
| SI (1) | SI1776587T1 (de) |
| WO (2) | WO2006015616A1 (de) |
| ZA (1) | ZA200701188B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1761779T3 (da) * | 2004-08-13 | 2008-02-25 | Indivumed Gmbh | Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem |
| EP1775590A1 (de) * | 2005-10-11 | 2007-04-18 | Laboratorios S.A.L.V.A.T., S.A. | Nicht invasive in vitro Methode zur Detektion von Transitionalzellkarzinomen der Harnblase |
| JP4748671B2 (ja) * | 2006-03-16 | 2011-08-17 | 日東紡績株式会社 | 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法 |
| KR100819122B1 (ko) | 2006-09-30 | 2008-04-04 | 남명진 | 췌장암 진단용 키트 |
| WO2009025080A1 (ja) * | 2007-08-18 | 2009-02-26 | School Juridical Person Kitasato Institute | 大腸癌マーカポリペプチド、及び大腸癌の診断方法 |
| JP5203687B2 (ja) * | 2007-12-12 | 2013-06-05 | シスメックス株式会社 | 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム |
| CN101838683B (zh) * | 2008-12-12 | 2013-09-18 | 深圳华大基因科技有限公司 | 一种kras基因和/或braf基因的核苷酸突变位点的检测方法 |
| CN102147396B (zh) * | 2010-02-10 | 2014-01-01 | 桑建利 | 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用 |
| JP2013253780A (ja) * | 2010-10-12 | 2013-12-19 | Katakura Industries Co Ltd | うつ病の診断のためのデータの提供方法 |
| US10158898B2 (en) | 2012-07-26 | 2018-12-18 | Comcast Cable Communications, Llc | Customized options for consumption of content |
| MX2015006757A (es) * | 2012-11-30 | 2015-11-30 | Applied Proteomics Inc | Método para la evaluación de la presencia de o riesgo de tumores de colon. |
| CN104056277B (zh) * | 2013-03-21 | 2019-07-05 | 中国人民解放军第二军医大学 | Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用 |
| US20170176441A1 (en) * | 2014-03-28 | 2017-06-22 | Applied Proteomics, Inc. | Protein biomarker profiles for detecting colorectal tumors |
| JP6750140B2 (ja) * | 2014-08-22 | 2020-09-02 | アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ | 直腸結腸がんを早期検出するための方法 |
| CN105988006A (zh) * | 2015-02-10 | 2016-10-05 | 张曼 | 尿液补体c3蛋白的应用 |
| CA2982169A1 (en) | 2015-04-10 | 2016-10-13 | Applied Proteomics, Inc. | Protein biomarker panels for detecting colorectal cancer and advanced adenoma |
| US20180092874A1 (en) * | 2016-10-03 | 2018-04-05 | Lincoln Memorial University | Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment |
| KR102018205B1 (ko) * | 2017-07-24 | 2019-09-05 | (주) 바이오인프라생명과학 | 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법 |
| GB201721569D0 (en) * | 2017-12-21 | 2018-02-07 | Belgian Volition Sprl | Method for the detection and treatment of colorectal adenomas |
| GB201808476D0 (en) * | 2018-05-23 | 2018-07-11 | Univ Liverpool | Biomarkers for colorectal cancer |
| WO2023282916A1 (en) | 2021-07-09 | 2023-01-12 | Guardant Health, Inc. | Methods of detecting genomic rearrangements using cell free nucleic acids |
| CN116449018B (zh) * | 2023-02-14 | 2023-09-05 | 浙江大学 | 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996298A (en) * | 1988-04-20 | 1991-02-26 | New England Deaconess Hospital Corporation | Marker for colorectal carcinoma and methods of detecting the same |
| US5654161A (en) | 1995-05-12 | 1997-08-05 | Chiron Diagnostics Corporation | Method for diagnosing prostate cancer |
| DE19711111C2 (de) | 1997-03-06 | 1999-09-02 | Schering Ag | In vitro Nachweis zur Erkennung von Darmtumoren |
| US6221621B1 (en) | 1997-03-06 | 2001-04-24 | Bard Diagnostic Sciences, Inc. | Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated |
| IL121134A0 (en) * | 1997-06-22 | 1997-11-20 | Yeda Res & Dev | Peptides and antiallergic compositions comprising them |
| US20020160394A1 (en) | 2001-01-24 | 2002-10-31 | Bayer Corporation | Regulation of transthyretin to treat obesity |
| AU2002316299A1 (en) | 2001-06-22 | 2003-01-08 | Merck And Co., Inc. | Ppar-alpha ligands for the treatment or prevention of cachexia |
| US7144708B2 (en) * | 2001-06-25 | 2006-12-05 | The Cleveland Clinic Foundation | Markers of blood barrier disruption and methods of using same |
| DE10224534A1 (de) | 2002-05-31 | 2003-12-11 | Juergen Dolderer | Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung |
| AU2002349786A1 (en) | 2002-06-19 | 2004-01-06 | Japan As Represented By The President Of The University Of Tokyo | Method for diagnosis of colorectal tumors |
| CN103969449B (zh) | 2002-08-06 | 2016-11-23 | 约翰霍普金斯大学 | 用于检测卵巢癌的生物标记的用途 |
| AU2004227018A1 (en) * | 2003-04-08 | 2004-10-21 | Colotech A/S | A method for detection of colorectal cancer in human samples |
| WO2005008251A2 (en) * | 2003-07-11 | 2005-01-27 | Praecis Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis |
| DE602004023545D1 (de) | 2004-08-13 | 2009-11-19 | Egomedical Technologies Ag | Analyttestsystem zur bestimmung der konzentration eines analyten in einer physiologischen oder wässrigen flüssigkeit |
| DK1761779T3 (da) | 2004-08-13 | 2008-02-25 | Indivumed Gmbh | Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem |
| US9075062B2 (en) | 2005-03-22 | 2015-07-07 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Identification of biomarkers by serum protein profiling |
-
2004
- 2004-08-13 DK DK04764118T patent/DK1761779T3/da active
- 2004-08-13 PL PL04764118T patent/PL1761779T3/pl unknown
- 2004-08-13 DE DE602004009716T patent/DE602004009716T2/de active Active
- 2004-08-13 ES ES04764118T patent/ES2295907T3/es active Active
- 2004-08-13 JP JP2007525176A patent/JP4916441B2/ja not_active Expired - Fee Related
- 2004-08-13 AT AT04764118T patent/ATE376674T1/de active
- 2004-08-13 PT PT04764118T patent/PT1761779E/pt unknown
- 2004-08-13 US US11/660,070 patent/US7951528B2/en not_active Expired - Fee Related
- 2004-08-13 AU AU2004322162A patent/AU2004322162B2/en not_active Ceased
- 2004-08-13 CA CA002577601A patent/CA2577601A1/en not_active Abandoned
- 2004-08-13 MX MX2007001479A patent/MX2007001479A/es unknown
- 2004-08-13 CN CNA2004800437997A patent/CN101014859A/zh active Pending
- 2004-08-13 EP EP07014481A patent/EP1843159A1/de not_active Withdrawn
- 2004-08-13 WO PCT/EP2004/009124 patent/WO2006015616A1/en active IP Right Grant
- 2004-08-13 EP EP04764118A patent/EP1761779B1/de not_active Not-in-force
- 2004-08-13 BR BRPI0419002-5A patent/BRPI0419002A/pt not_active IP Right Cessation
-
2005
- 2005-08-11 AT AT05772471T patent/ATE419534T1/de active
- 2005-08-11 EP EP05772471A patent/EP1776587B9/de not_active Not-in-force
- 2005-08-11 CN CNA2005800276025A patent/CN101014861A/zh active Pending
- 2005-08-11 CA CA002576998A patent/CA2576998A1/en not_active Abandoned
- 2005-08-11 DE DE602005012108T patent/DE602005012108D1/de active Active
- 2005-08-11 ES ES05772471T patent/ES2322378T3/es active Active
- 2005-08-11 MX MX2007001254A patent/MX2007001254A/es active IP Right Grant
- 2005-08-11 SI SI200530641T patent/SI1776587T1/sl unknown
- 2005-08-11 US US11/660,066 patent/US7883842B2/en not_active Expired - Fee Related
- 2005-08-11 WO PCT/EP2005/008742 patent/WO2006053592A1/en active Application Filing
- 2005-08-11 PL PL05772471T patent/PL1776587T3/pl unknown
- 2005-08-11 PT PT05772471T patent/PT1776587E/pt unknown
- 2005-08-11 AU AU2005306103A patent/AU2005306103A1/en not_active Abandoned
- 2005-08-11 JP JP2007525256A patent/JP4592753B2/ja not_active Expired - Fee Related
- 2005-08-11 ZA ZA200701188A patent/ZA200701188B/xx unknown
- 2005-08-11 DK DK05772471T patent/DK1776587T3/da active
- 2005-08-11 KR KR1020077005868A patent/KR20070051328A/ko not_active Application Discontinuation
-
2007
- 2007-01-31 NO NO20070598A patent/NO20070598L/no not_active Application Discontinuation
- 2007-01-31 NO NO20070599A patent/NO20070599L/no not_active Application Discontinuation
- 2007-02-01 IL IL181132A patent/IL181132A/en not_active IP Right Cessation
- 2007-02-01 IL IL181131A patent/IL181131A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE419534T1 (de) | Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit | |
| RU2018124339A (ru) | Способ и система для сенсорного обнаружения посредством модифицированной наноструктуры | |
| ATE508360T1 (de) | Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde | |
| ATE548656T1 (de) | Verfahren zur identifizierung von patienten mit erhöhter wahrscheinlichkeit des auftretens eines ovarialkarzinoms und zusammensetzungen dafür | |
| DE502005006434D1 (de) | Vorrichtung und verfahren zum nachweis von geladenen makromolekülen | |
| DE60332639D1 (de) | Verwendung von biomarkern zum nachweis von eierstockkrebs | |
| WO2008109075A3 (en) | Biomarkers and methods for determining sensitivity to ctla-4 antagonists | |
| DE602006018744D1 (de) | Strategien mit hohem durchsatz zur identifizierung und zum nachweis von polymorphismen | |
| ATE556030T1 (de) | Ultrasensitiver nachweis von analyten | |
| ATE472110T1 (de) | Sensoreinrichtung und verfahren zur erfassung von magnetischen teilchen | |
| WO2008095152A3 (en) | Methods and materials for identifying the origin of a carcinoma of unknown primary origin | |
| ATE408829T1 (de) | Verfahren und assaykits zum nachweis mononuklearer zellphänotypen | |
| ECSP056124A (es) | Método y dispositivo para detectar analitos volátiles en muestras de aire | |
| EA201190026A1 (ru) | Ценный документ, способ изготовления контрольного элемента и способ обнаружения загрязнения или истирания документа | |
| EA200500355A1 (ru) | Способ обнаружения, характеристики и мониторинга углеводородных месторождений | |
| DE60315715D1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| WO2010009074A3 (en) | Method for predicting and detecting tumor metastasis | |
| ATE499612T1 (de) | Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem | |
| WO2014044791A3 (en) | Methods and kits for predicting the sensitivity of a subject to chemotherapy | |
| ATE522833T1 (de) | Vorrichtung zur detektion von chemischen oder biologischen substanzen und verfahren zum reinigen der vorrichtung | |
| ATE513228T1 (de) | Verfahren zur erfassung und messung von parametern von funksignalen | |
| WO2008060676A3 (en) | System and method for resolving gamma-ray spectra |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1761779 Country of ref document: EP |